Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewAutoimmunityCell biologyEndocrinology Open Access | 10.1172/JCI195267

Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes

Theodore dos Santos,1 Xiao-Qing Dai,1 Robert C. Jones,2 Aliya F. Spigelman,1 Hannah M. Mummey,3 Jessica D. Ewald,4 Cara E. Ellis,1 James G. Lyon,5 Nancy Smith,1 Austin Bautista,6 Jocelyn E. Manning Fox,1 Norma F. Neff,7 Angela M. Detweiler,7 Michelle Tan,7 Rafael Arrojo e Drigo,8 Jianguo Xia,9 Joan Camunas-Soler,10 Kyle J. Gaulton,11 Stephen R. Quake,12 and Patrick E. MacDonald6

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by dos Santos, T. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Dai, X. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Jones, R. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Spigelman, A. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Mummey, H. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Ewald, J. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Ellis, C. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Lyon, J. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Smith, N. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Bautista, A. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Manning Fox, J. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Neff, N. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Detweiler, A. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Tan, M. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Arrojo e Drigo, R. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Xia, J. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Camunas-Soler, J. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Gaulton, K. in: PubMed | Google Scholar |

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by Quake, S. in: PubMed | Google Scholar

1Department of Pharmacology, University of Alberta, Edmonton, Canada

2Department of Bioengineering, Stanford University, Stanford, United States of America

3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America

4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada

6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada

7Chan Zuckerberg Biohub, San Francisco, United States of America

8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America

9Department of Microbiology & Immunology, McGill University, Montreal, Canada

10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America

11Department of Pediatrics, University of California San Diego, La Jolla, United States of America

12Department of Bioengineering, Stanford University, Stanford, United States of America

Find articles by MacDonald, P. in: PubMed | Google Scholar |

Published September 30, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI195267.
Copyright © 2025, dos Santos et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published September 30, 2025 - Version history
View PDF
Abstract

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of most insulin-producing β-cells, along with dysregulated glucagon secretion from pancreatic α-cells. We conducted an integrated analysis that combines electrophysiological and transcriptomic profiling, along with machine learning, of islet cells from T1D donors. The few surviving β-cells exhibit altered electrophysiological properties and transcriptomic signatures indicative of increased antigen presentation, metabolic reprogramming, and impaired protein translation. In α-cells, we observed hyper-responsiveness and increased exocytosis, which are associated with upregulated immune signaling, disrupted transcription factor localization and lysosome homeostasis, as well as dysregulation of mTORC1 complex signaling. Notably, key genetic risk signals for T1D were enriched in transcripts related to α-cell dysfunction, including MHC class I, which were closely linked with α-cell dysfunction. Our data provide what we believe are novel insights into the molecular underpinnings of islet cell dysfunction in T1D, highlighting pathways that may be leveraged to preserve residual β-cell function and modulate α-cell activity. These findings underscore the complex interplay between immune signaling, metabolic stress, and cellular identity in shaping islet cell phenotypes in T1D.

Graphical Abstract
graphical abstract
Supplemental material

View Suppl Table 1

View Suppl Table 2

View Suppl Table 3

View Suppl Table 4

View Suppl Table 5

View

Version history
  • Version 1 (September 30, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts